Impact of switching from an open to a closed infusion system on rates of central line-associated bloodstream infection: A meta-analysis of time-sequence cohort studies in 4 countries

Infection Control and Hospital Epidemiology

Volumn 32, Issue 1, 2011, Pages 50-58

  Maki, Dennis G ^a   Rosenthal, Victor D ^b   Salomao, Reinaldo ^c   Franzetti, Fabio ^d   Sigfrido Rangel Frausto, Manuel ^e  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b Bernal Medical Center   (Argentina)

^c HOSPITAL SANTA MARCELINA   (Brazil)

^d UNIVERSITY OF MILAN   (Italy)

^e INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARGENTINA; ARTICLE; BRAZIL; CATHETER CARE; CATHETER INFECTION; CENTRAL LINE ASSOCIATED BLOODSTREAM INFECTION; COHORT ANALYSIS; CONFIDENCE INTERVAL; FEMALE; HUMAN; HYGIENE; INCIDENCE; INFECTION CONTROL; INFUSION SYSTEM; INTENSIVE CARE UNIT; ITALY; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MEXICO; MORTALITY; RISK FACTOR;

ADULT; AGED; ARGENTINA; BRAZIL; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; COHORT STUDIES; FEMALE; HUMANS; INFECTION CONTROL; INTENSIVE CARE UNITS; ITALY; MALE; MEXICO; MIDDLE AGED; SEPSIS;

EID: 78650777068     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/657632     Document Type: Article

References (54)

1. Jarvis WR. Selected aspects of the socioeconomic impact of nosocomial infections: morbidity, mortality, cost, and prevention. Infect Control Hosp Epidemiol 1996;17(8):552-557.
2. Laupland KB, Zygun DA, Doig CJ, Bagshaw SM, Svenson LW, Fick GH. One-year mortality of bloodstream infection-associated sepsis and septic shock among patients presenting to a regional critical care system. Intensive Care Med 2005;31(2):213-219.
3. Maki DG, Goldman DA, Rhame FS. Infection control in intravenous therapy. Ann Intern Med 1973;79(6):867-887.
4. Maki DG. Nosocomial bacteremia: an epidemiologic overview. Am J Med 1981;70(3):719-732.
5. Bjornson HS, Colley R, Bower RH, Duty VP, Schwartz-Fulton JT, Fischer JE. Association between microorganism growth at the catheter insertion site and colonization of the catheter in patients receiving total parenteral nutrition. Surgery 1982;92(4):720-727.
6. Cooper GL, Hopkins CC. Rapid diagnosis of intravascular catheter-associated infection by direct Gram staining of catheter segments.NEngl J Med 1985;312(18):1142-1147.
7. Maki DG, Stolz SM, Wheeler S, Mermel LA. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter: a randomized, controlled trial. Ann Intern Med 1997; 127(4):257-266.
8. Safdar N, Maki DG. The pathogenesis of catheter-related bloodstream infection with noncuffed short-term central venous catheters. Intensive Care Med 2004;30(1):62-67.
9. Maki DG, Rhame FS, Mackel DC, Bennett JV. Nationwide epidemic of septicemia caused by contaminated intravenous products. I. Epidemiologic and clinical features. Am J Med 1976;60(4):471-485.
10. Maki DG, Anderson RL, Shulman JA. In-use contamination of intravenous infusion fluid. Appl Microbiol 1974;28(5):778-784.
11. Macias AE, Munoz JM, Galvan A, et al. Nosocomial bacteremia in neonates related to poor standards of care. Pediatr Infect Dis J 2005;24(8): 713-716.
12. Clinical sepsis and death in a newborn nursery associated with contaminated parenteral medications-Brazil, 1996. MMWR Morb Mortal Wkly Rep 1998;47(29):610-612.
13. Garrett DO, McDonald LC, Wanderley A, et al. An outbreak of neonatal deaths in Brazil associated with contaminated intravenous fluids. J Infect Dis 2002;186(1):81-86.
14. Matsaniotis NS, Syriopoulou VP, Theodoridou MC, Tzanetou KG, Mostrou GI. Enterobacter sepsis in infants and children due to contaminated intravenous fluids. Infect Control 1984;5(10):471-477.
15. Moore KL, Kainer MA, Badrawi N, et al. Neonatal sepsis in Egypt associated with bacterial contamination of glucose-containing intravenous fluids. Pediatr Infect Dis J 2005;24(7):590-594.
16. Macias AE, Munoz JM, Bruckner DA, et al. Parenteral infusions bacterial contamination in a multi-institutional survey in Mexico: considerations for nosocomial mortality. Am J Infect Control 1999;27(3):285-290.
17. Rosenthal VD, Guzman S, Crnich C. Device-associated nosocomial infection rates in intensive care units of Argentina. Infect Control Hosp Epidemiol 2004;25(3):251-255.
18. Rangel-Frausto MS, Higuera-Ramirez F, Martinez-Soto J, Rosenthal VD. Should we use closed or open infusion containers for prevention of bloodstream infections? Ann Clin Microbiol Antimicrob 2010;9:6.
19. Vilins M, Blecher S, Maretti da Silva MA, Rosenthal VD, Barker K, Salomao R. Rate and time to develop first central line-associated bloodstream infections when comparing open and closed infusion containers in a Brazilian hospital. Braz J Infect Dis 2009; 13(5):335-340.
20. Franzetti F, Borghi B, Raimondi F, Rosenthal VD. Impact on rates and time to first central vascular-associated bloodstream infection when switching from open to closed intravenous infusion containers in a hospital setting. Epidemiol Infect 2009;137(7):1041-1048.
21. Rosenthal VD, Maki DG, Mehta A, et al. International Nosocomial Infection Control Consortium report, data summary for 2002-2007, issued January 2008. Am J Infect Control 2008;36(9):627-637.
22. Rosenthal VD, Maki DG, Graves N. The International Nosocomial Infection Control Consortium (INICC): goals and objectives, description of surveillance methods, and operational activities. Am J Infect Control 2008;36(9):e1-e12.
23. Rosenthal VD, Maki DG, Jamulitrat S, et al. International Nosocomial Infection Control Consortium (INICC) report, data summary for 2003-2008, issued June 2009. Am J Infect Control 2010;38(2):95-104.e2.
24. Edwards JR, Peterson KD, Andrus ML, Dudeck MA, Pollock DA, Horan TC. National Healthcare Safety Network (NHSN) report, data summary for 2006 through 2007, issued November 2008. Am J Infect Control 2008;36(9):609-626.
25. Emori TG, Culver DH, Horan TC, et al. National Nosocomial Infections Surveillance system (NNIS): description of surveillance methods. Am J Infect Control 1991;19(1):19-35.
26. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008;36(5):309-332.
27. Rosenthal VD, Guzman S, Crnich C. Impact of an infection control program on rates of ventilator-associated pneumonia in intensive care units in 2 Argentinean hospitals. Am J Infect Control 2006;34(2):58-63.
28. Rosenthal VD, Guzman S, Pezzotto SM, Crnich CJ. Effect of an infection control program using education and performance feedback on rates of intravascular device-associated bloodstream infections in intensive care units in Argentina. Am J Infect Control 2003;31(7):405-409.
29. Rosenthal VD, Guzman S, Safdar N. Reduction in nosocomial infection with improved hand hygiene in intensive care units of a tertiary care hospital in Argentina. Am J Infect Control 2005;33(7):392-397.
30. Rosenthal VD, Guzman S, Safdar N. Effect of education and performance feedback on rates of catheter-associated urinary tract infection in intensive care units in Argentina. Infect Control Hosp Epidemiol 2004;25(1): 47-50.
31. Maki DG, Weise CE, Sarafin HW. A semiquantitative culture method for identifying intravenous catheter-related infection. N Engl J Med 1977; 296(23):1305-1309.
32. Sutton AJ. Methods for Meta-Analysis in Medical Research. Chichester, England: Wiley; 2000.
33. Blettner M, Sauerbrei W, Schlehofer B, Scheuchenpflug T, Friedenreich C. Traditional reviews, meta-analyses and pooled analyses in epidemiology. Int J Epidemiol 1999;28(1):1-9.
34. Mattie AS, Webster BL. Centers for Medicare and Medicaid Services' "never events": an analysis and recommendations to hospitals. Health Care Manag (Frederick) 2008;27(4):338-349.
35. Posa PJ, Harrison D, Vollman KM. Elimination of central line-associated bloodstream infections: application of the evidence. AACN Adv Crit Care 2006;17(4):446-454.
36. Chaberny IF, Ruseva E, Sohr D, et al. Surveillance with successful reduction of central line-associated bloodstream infections among neutropenic patients with hematologic or oncologic malignancies. Ann Hematol 2009;88(9):907-912.
37. Costello JM, Morrow DF, Graham DA, Potter-Bynoe G, Sandora TJ, Laussen PC. Systematic intervention to reduce central line-associated bloodstream infection rates in a pediatric cardiac intensive care unit. Pediatrics 2008;121(5):915-923.
38. Warren DK, Zack JE, Mayfield JL, et al. The effect of an education program on the incidence of central venous catheter-associated bloodstream infection in a medical ICU. Chest 2004;126(5):1612-1618.
39. Ramritu P, Halton K, Cook D, Whitby M, Graves N. Catheter-related bloodstream infections in intensive care units: a systematic review with meta-analysis. J Adv Nurs 2008;62(1):3-21.
40. Rossello-Urgell J. Nosocomial infection surveillance and control activities in Spain under HELICS and NosoMed programs frame. J Hosp Infect 2004;56(suppl 2):S55-S57.
41. Rosenthal VD. Device-associated nosocomial infections in limited-resources countries: findings of the International Nosocomial Infection Control Consortium (INICC). Am J Infect Control 2008;36(10):S171 e7-e12.
42. Raka L. Lowbury Lecture 2008: infection control and limited resources- searching for the best solutions. J Hosp Infect 2009;72(4):292-298.
43. Huskins WC, Soule BM, O'Boyle C, Gulacsi L, O'Rourke EJ, Goldmann DA. Hospital infection prevention and control: a model for improving the quality of hospital care in low- and middle-income countries. Infect Control Hosp Epidemiol 1998;19(2):125-135.
44. Rosenthal VD, Maki DG. Prospective study of the impact of open and closed infusion systems on rates of central venous catheter-associated bacteremia. Am J Infect Control 2004;32(3):135-141.
45. Rosenthal VD. Central line-associated bloodstream infections in limitedresource countries: a review of the literature. Clin Infect Dis 2009;49(12): 1899-1907.
46. van der Kooi TI, de Boer AS, Mannien J, et al. Incidence and risk factors of device-associated infections and associated mortality at the intensive care in the Dutch surveillance system. Intensive Care Med 2007;33(2): 271-278.
47. Renaud B, Brun-Buisson C. Outcomes of primary and catheter-related bacteremia: a cohort and case-control study in critically ill patients. Am J Respir Crit Care Med 2001;163(7):1584-1590.
48. Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients: excess length of stay, extra costs, and attributable mortality. JAMA 1994;271(20):1598-1601.
49. Vanholder V, Hoenich N, Ringoir S. Morbidity and mortality of central venous catheter hemodialysis: a review of 10 years' experience. Nephron 1987;47(4):274-279.
50. Maki DG, Kluger DM, Crnich CJ. The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clin Proc 2006;81(9):1159-1171.
51. Crnich CJ, Maki DG. The promise of novel technology for the prevention of intravascular device-related bloodstream infection. I. Pathogenesis and short-term devices. Clin Infect Dis 2002;34(9):1232-1242.
52. Crnich CJ, Maki DG. The role of intravascular devices in sepsis. Curr Infect Dis Rep 2001;3(6):496-506.
53. Ivy DD, Calderbank M, Wagner BD, et al. Closed-hub systems with protected connections and the reduction of risk of catheter-related bloodstream infection in pediatric patients receiving intravenous prostanoid therapy for pulmonary hypertension. Infect Control Hosp Epidemiol 2009; 30(9):823-829.
54. Rosenthal VD, Franzetti F, Salomao R, et al. Impact of switching from an open to a closed infusion container on incidence of microorganisms associated with central line-associated bloodstream infection in Latin America and Europe. Paper presented at: 19th Annual Scientific Meeting of the Society for Healthcare Epidemiology of America; March 19-22, 2009; San Diego, CA.